HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anbupalam Thalamuthu Selected Research

Anbupalam Thalamuthu Research Topics

Disease

8Cognitive Dysfunction
01/2024 - 12/2015
8Bipolar Disorder (Manic Depressive Psychosis)
12/2023 - 11/2021
8Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2016
7Genetic Risk Score
07/2022 - 04/2016
4Stroke (Strokes)
01/2024 - 01/2019
4Hypertension (High Blood Pressure)
01/2023 - 01/2019
4Schizophrenia (Dementia Praecox)
07/2022 - 03/2016
3Infections
05/2013 - 01/2011
2Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 01/2019
2Inflammation (Inflammations)
01/2016 - 09/2007
2Neoplasms (Cancer)
03/2012 - 07/2010
2Breast Neoplasms (Breast Cancer)
04/2011 - 01/2010
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2024
1Mania (Manias)
12/2023
1Psychotic Disorders (Schizoaffective Disorder)
12/2023
1Alcoholism (Alcohol Abuse)
12/2023
1Mental Disorders (Mental Disorder)
02/2023
1Dementia (Dementias)
01/2023
1Chronic Renal Insufficiency
01/2023
1Atrophy
01/2021
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
01/2020
1Major Depressive Disorder (Major Depressive Disorders)
11/2019
1Infarction (Infarctions)
01/2019
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
01/2019
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2019
1Cardiomyopathies (Cardiomyopathy)
01/2019
1Atrial Fibrillation
01/2019
1Neurodegenerative Diseases (Neurodegenerative Disease)
03/2016
1Disease Progression
05/2013
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2012
1Lymphoma (Lymphomas)
03/2012
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
03/2012
1Chronic Hepatitis B
10/2011
1Choroidal Neovascularization
01/2011
1Polypoidal Choroidal Vasculopathy
01/2011
1Ischemic Stroke
01/2011
1Endometrial Neoplasms (Endometrial Cancer)
07/2010
1Exfoliation Syndrome
06/2009
1Glaucoma
06/2009
1Microphthalmos
07/2008
1Rheumatoid Arthritis
09/2007
1Macular Degeneration (Age-Related Maculopathy)
07/2005

Drug/Important Bio-Agent (IBA)

8Biomarkers (Surrogate Marker)IBA
01/2024 - 12/2015
8LithiumIBA
12/2023 - 11/2021
5ApolipoproteinsIBA
01/2022 - 04/2016
5MicroRNAs (MicroRNA)IBA
01/2020 - 01/2011
4Apolipoproteins E (ApoE)IBA
01/2022 - 04/2016
3LipidsIBA
01/2021 - 01/2019
2Cholinergic Agents (Cholinergics)IBA
07/2023 - 02/2023
2Antihypertensive Agents (Antihypertensives)IBA
01/2023 - 01/2021
2Amyloid (Amyloid Fibrils)IBA
01/2022 - 01/2020
2CholesterolIBA
01/2019 - 01/2019
2Genetic Markers (Genetic Marker)IBA
03/2016 - 01/2010
2Complement System Proteins (Complement)IBA
01/2016 - 07/2005
2Proteins (Proteins, Gene)FDA Link
01/2016 - 03/2012
2Messenger RNA (mRNA)IBA
05/2013 - 01/2011
2AndrogensIBA
04/2011 - 07/2010
2Estrogen ReceptorsIBA
07/2010 - 01/2010
1Eicosapentaenoic AcidIBA
01/2023
1docosapentaenoic acidIBA
01/2023
1Docosahexaenoic AcidsIBA
01/2023
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2023
1alpha-Linolenic Acid (Linolenic Acid)IBA
01/2023
1ProteomeIBA
01/2016
1Heparin Cofactor IIIBA
01/2016
1histidine-rich proteinsIBA
01/2016
1Apolipoproteins AIBA
01/2016
1Phosphotransferases (Kinase)IBA
03/2012
1Tyrosine Kinase InhibitorsIBA
03/2012
1ErbB Receptors (EGF Receptor)IBA
03/2012
1HLA-DR Antigens (HLA-DR)IBA
10/2011
1HLA-DP Antigens (HLA-DP)IBA
10/2011
1VaccinesIBA
10/2011
1HomocysteineIBA
01/2011
15,10-methylenetetrahydrofolic acidIBA
01/2011
1Oxidoreductases (Dehydrogenase)IBA
01/2011
1Toll-Like Receptor 3IBA
01/2011
1Estrogens (Estrogen)FDA Link
07/2010
1Hormones (Hormone)IBA
07/2010
1Indicators and Reagents (Reagents)IBA
01/2010
1Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
06/2009
1WD repeat containing planar cell polarity effectorIBA
07/2008
1Retinaldehyde (Retinal)IBA
07/2008
1Complement C5 (Complement 5)IBA
09/2007
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
09/2007
1Anti-Citrullinated Protein AntibodiesIBA
09/2007
1TNF Receptor-Associated Factor 1IBA
09/2007
1Fatty Acids (Saturated Fatty Acids)IBA
07/2005

Therapy/Procedure

3Therapeutics
11/2021 - 05/2013
1Patient Readmission
11/2019